Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsIn high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.
Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.
1.
We Don't Always Know What's 'Best' for Our Patients
2.
Best foot forward—chemo care should include podiatry, say researchers
3.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
4.
In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.
5.
investigating radiation oncology applications of artificial general intelligence.
1.
The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery
2.
Advanced Methods in Oncology in Daily Practice
3.
Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities
4.
Exploring the Unknown: Unveiling the Mysteries of GIST Tumors
5.
Innovative Practices in Hematology in the Digital Era
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
5.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge